Rahul Aras


Doubling down on regenerative medicine: Juventas and SironRX

Many business professionals likely dream of the day when they’ll run a company as chief executive, but how many hope to lead two startups simultaneously? As CEO of Cleveland-based regenerative medicine startups Juventas Therapeutics and SironRX Therapeutics, Rahul Aras is doing just that. Each company is developing therapies based off the same technology, a growth […]

presented by

Juventas Therapeutics starts Phase 1 trial for heart failure

Clinical-stage regenerative medicine company Juventas Therapeutics Inc.–a Cleveland Clinic spin-off initially named AccelleRX–has started enrolling patients in a Phase 1 clinical trial to evaluate the safety and efficacy of its leading stem cell factor for treating heart failure. In preclinical studies of heart failure in pigs, JVS-100, as the factor is known, significantly increased cardiac […]